Shi Li

Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial

Brian I. Rini, Thomas Powles, Michael B. Atkins et al. · The Lancet · 2019 · 1K citations

Medicine, Oncology, Pharmacology +13

Stapokibart for moderate-to-severe seasonal allergic rhinitis: a randomized phase 3 trial

Yuan Zhang, Jingyun Li, Menglin Wang et al. · Nature Medicine · 2025 · 35 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Interim Effectiveness and Safety Comparison of Bedaquiline-Containing Regimens for Treatment of Diabetic Versus Non-Diabetic MDR/XDR-TB Patients in China: A Multicenter Retrospective Cohort Study

Shi Li, Jingtao Gao, Mengqiu Gao et al. · Infectious Diseases and Therapy · 2021 · 29 citations · Full text

Pharmacy, Internal Medicine, Pharmacotherapy +15

Red blood cell distribution width as a predictor of survival in nasal-type, extranodal natural killer/T-cell lymphoma

Huaichao Luo, Xiaoying Quan, Li Zhang et al. · Oncotarget · 2017 · 20 citations · Full text

Veterinary Medicine, Hematology, Oncology +9

A Novel Nomogram for Predicting Postsurgical Intra-abdominal Infection in Gastric Cancer Patients: a Prospective Study

Chenchen Mao, Ji Lin, Weishan Zhuge et al. · Journal of Gastrointestinal Surgery · 2018 · 15 citations

Medicine, Oncology, Surgery +14